Long-term assessment of cardiac function after dose-dense and -intense sequential doxorubicin (A), paclitaxel (T), and cyclophosphamide (C) as adjuvant therapy for high risk breast cancer

Maysa M. Abu-Khalaf, Vinni Juneja, Gina G. Chung, Michael P. DiGiovanna, Rebecca Sipples, Meghan McGurk, Daniel Zelterman, Bruce Haffty, Michael Reiss, Frans J. Wackers, Forrester A. Lee, Barbara A. Burtness

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Fingerprint Dive into the research topics of 'Long-term assessment of cardiac function after dose-dense and -intense sequential doxorubicin (A), paclitaxel (T), and cyclophosphamide (C) as adjuvant therapy for high risk breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences